Merops Switch to
Peptidases

Inhibitor

Family Clan Small-molecule
inhibitor SEARCHES BLAST
MEROPS

Other
information

Literature for inhibitor I04.023: plasmin inhibitor

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature

(Topics flags: S Structure, A Assay, M Mutation, I Inhibitor, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2022
  1. Alsayejh,B., Kietsiriroje,N., Almutairi,M., Simmons,K., Pechlivani,N., Ponnambalam,S. and Ajjan,R.A.
    Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target
    TH Open6, e396-e396. PubMed  Europe PubMed DOI  V
    2. 2021
  2. Bronic,A., Ferencak,G., Bernat,R., Lenicek-Krleza,J., Dumic,J. and Dabelic,S.
    Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease
    J Med Biochem40, 138-149. PubMed  Europe PubMed DOI
    3. 2020
  3. Nougier,C., Benoit,R., Simon,M., Desmurs-Clavel,H., Marcotte,G., Argaud,L., David,J.S., Bonnet,A., Negrier,C. and Dargaud,Y.
    Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis
    J Thromb Haemost PubMed  Europe PubMed DOI
  4. Pedersen,N.B., Stolberg,C.R., Mundbjerg,L.H., Juhl,C.B., Gram,B., Funch-Jensen,P., de Maat,M.P.M., Munster,A.B. and Bladbjerg,E.M.
    Reductions in plasmin inhibitor and fibrinogen predict the improved fibrin clot lysis 6 months after obesity surgery
    Clin Obese12397-e12397. PubMed  Europe PubMed DOI
  5. Singh,S., Saleem,S. and Reed,G.L.
    Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease
    Front Cardiovasc Med7, 608899-608899. PubMed  Europe PubMed DOI  V
  6. Verbree-Willemsen,L., Zhang,Y.N., Ibrahim,I., Ooi,S.B.S., Wang,J.W., Mazlan,M.I., Kuan,W.S., Chan,S.P., Peelen,L.M., Grobbee,D.E., Richards,A.M., Lam,C.S.P. and de Kleijn,D.P.V.
    Extracellular vesicle Cystatin C and CD14 are associated with both renal dysfunction and heart failure
    ESC Heart Fail7, 2240-2249. PubMed  Europe PubMed DOI
    7. 2019
  7. Teraz-Orosz,A., Csapo,A., Bagoly,Z., Szekely,E.G., Toth,E., Kovacs,B., Bereczky,Z., Muszbek,L. and Katona,E.
    A new ELISA method for the measurement of total alpha2-plasmin inhibitor level in human body fluids
    J Immunol Methods471, 27-33. PubMed  Europe PubMed DOI  A
    8. 2018
  8. Vigano,S., D'Andrea,G., Valle,P.D., Santacroce,R., Margaglione,M. and D'Angelo,A.
    A novel allele variant of the SERPINF2 gene responsible for severe plasmin inhibitor (alpha2-antiplasmin) deficiency in an Italian patient
    Thromb Res166, 60-62. PubMed  Europe PubMed DOI  M
    9. 2015
  9. Eddy,J.L., Schroeder,J.A., Zimbler,D.L., Bellows,L.E. and Lathem,W.W.
    Impact of the Pla protease substrate alpha2-antiplasmin on the progression of primary pneumonic plague
    Infect Immun83, 4837-4847. PubMed  Europe PubMed DOI
    10. 2011
  10. Lu,B.G., Sofian,T., Law,R.H., Coughlin,P.B. and Horvath,A.J.
    Contribution of conserved lysine residues in the alpha2-antiplasmin C terminus to plasmin binding and inhibition
    J Biol Chem286, 24544-24552. PubMed  Europe PubMed DOI
  11. Uitte de Willige,S., Miedzak,M., Carter,A.M., Lisman,T., Rosendaal,F.R., Grant,P.J., Philippou,H. and Ariens,R.A.
    Proteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarction
    Blood117, 6694-6701. PubMed  Europe PubMed DOI
    12. 2008
  12. Carpenter,S.L. and Mathew,P.
    Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance
    Haemophilia14, 1250-1254. PubMed  Europe PubMed DOI  V
  13. Law,R.H., Sofian,T., Kan,W.T., Horvath,A.J., Hitchen,C.R., Langendorf,C.G., Buckle,A.M., Whisstock,J.C. and Coughlin,P.B.
    X-ray crystal structure of the fibrinolysis inhibitor alpha2-antiplasmin
    Blood111, 2049-2052. PubMed  Europe PubMed DOI  S
  14. Maino,A., Garagiola,I., Artoni,A., Al-Humood,S. and Peyvandi,F.
    A novel mutation of alpha2-plasmin inhibitor gene causes an inherited deficiency and a bleeding tendency
    Haemophilia14, 166-166. PubMed  Europe PubMed DOI  M
    15. 2007
  15. Sazonova,I.Y., Thomas,B.M., Gladysheva,I.P., Houng,A.K. and Reed,G.L.
    Fibrinolysis is amplified by converting alpha-antiplasmin from a plasmin inhibitor to a substrate
    J Thromb Haemost5, 2087-2094. PubMed  Europe PubMed DOI
    16. 2006
  16. Gallimore,M.J.
    More on: Discovery of alpha2-plasmin inhibitor and its congenital deficiency
    J Thromb Haemost4, 284-285. PubMed  Europe PubMed DOI
    17. 2005
  17. Aoki,N.
    The past, present and future of plasmin inhibitor
    Thromb Res116, 455-464. PubMed  Europe PubMed DOI  V
  18. Aoki,N.
    Discovery of alpha2-plasmin inhibitor and its congenital deficiency
    J Thromb Haemost3, 623-631. PubMed  Europe PubMed DOI
  19. Coughlin,P.B.
    Antiplasmin: the forgotten serpin?
    FEBS J272, 4852-4857. PubMed  Europe PubMed DOI  V
    20. 2003
  20. [YEAR:4-2-2003]Frank,P.S., Douglas,J.T., Locher,M., Llinas,M. and Schaller,J.
    Structural/functional characterization of the alpha2-plasmin inhibitor C-terminal peptide
    Biochemistry42, 1078-1085. PubMed  Europe PubMed DOI
    21. 2002
  21. [YEAR:5-3-2002]Hsieh,M.C. and Cooperman,B.S.
    Inhibition of prostate-specific antigen (PSA) by alpha(1)-antichymotrypsin: salt-dependent activation mediated by a conformational change
    Biochemistry41, 2990-2997. PubMed  Europe PubMed DOI
    22. 2001
  22. [YEAR:11-6-2001]Lijnen,H.R., Van Hoef,B. and Collen,D.
    Inactivation of the serpin alpha(2)-antiplasmin by stromelysin-1
    Biochim Biophys Acta1547, 206-213. PubMed  Europe PubMed DOI
    23. 1998
  23. Und,B. and Thorsen,S.
    A new mutation (Val384Met) in the human plasmin inhibitor gene associated with plasmin inhibitor deficiency and bleeding tendency
    Fibrinolysis Proteolysis12 Suppl. 1, 20-20.  M
    24. 1993
  24. Bangert,K., Johnsen,A.H., Christensen,U. and Thorsen,S.
    Different N-terminal forms of alpha2-plasmin inhibitor in human plasma
    Biochem J291, 623-625. PubMed  Europe PubMed
    25. 1992
  25. Christensen,S. and Sottrup-Jensen,L.
    Bovine alpha2-antiplasmin. N-terminal and reactive site sequence
    FEBS Lett312, 100-104. PubMed  Europe PubMed DOI
    26. 1989
  26. Shieh,B.H., Potempa,J. and Travis,J.
    The use of alpha2-antiplasmin as a model for the demonstration of complex reversibility in serpins
    J Biol Chem264, 13420-13423. PubMed  Europe PubMed
    27. 1988
  27. [YEAR:15-9-1988]Hortin,G.L., Gibson,B.L. and Fok,K.F.
    Alpha 2-antiplasmin's carboxy-terminal lysine residue is a major site of interaction with plasmin
    Biochem Biophys Res Commun155, 591-596. PubMed  Europe PubMed
  28. [YEAR:5-8-1988]Potempa,J., Shieh,B.H. and Travis,J.
    Alpha-2-antiplasmin: a serpin with two separate but overlapping reactive sites
    Science241, 699-700. PubMed  Europe PubMed
  29. [YEAR:4-1-1988]Sugiyama,N., Sasaki,T., Iwamoto,M. and Abiko,Y.
    Binding site of alpha 2-plasmin inhibitor to plasminogen
    Biochim Biophys Acta952, 1-7. PubMed  Europe PubMed  I
    30. 1987
  30. Shieh,B.H. and Travis,J.
    The reactive site of human alpha 2-antiplasmin
    J Biol Chem262, 6055-6059. PubMed  Europe PubMed
    31. 1986
  31. Lijnen,H.R. and Collen,D.
    alpha2-Antiplasmin
    [ISSN:0-444-80763-2] (1986) 457-476.
    32. 1984
  32. [YEAR:1-9-1984]Hogstorp,H., Jacobsson,H., Wallin,R. and Saldeen,T.
    Two forms of alpha 2-antiplasmin: differences in KAV and isoelectric point
    Thromb Res35, 559-565. PubMed  Europe PubMed
  33. [YEAR:15-2-1984]Kluft,C., Los,P. and Jie,A.F.
    The molecular form of alpha 2-antiplasmin with affinity for plasminogen is selectively bound to fibrin by factor XIII
    Thromb Res33, 419-425. PubMed  Europe PubMed
    34. 1983
  34. [YEAR:15-7-1983]Gogstad,G.O., Stormorken,H. and Solum,N.O.
    Platelet alpha 2-antiplasmin is located in the platelet alpha-granules
    Thromb Res31, 387-390. PubMed  Europe PubMed
  35. [YEAR:21-3-1983]Ichinose,A., Tamaki,T. and Aoki,N.
    Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha 2-plasmin inhibitor to fibrin
    FEBS Lett153, 369-371. PubMed  Europe PubMed DOI
    36. 1982
  36. Kluft,C., Vellenga,E., Brommer,E.J. and Wijngaards,G.
    A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasmin
    Blood59, 1169-1180. PubMed  Europe PubMed  M  I
  37. Lijnen,H.R., Wiman,B., Van Hoef,B. and Collen,D.
    Purification and partial primary structure of cyanogen bromide fragments from human alpha2-antiplasmin
    Thromb Res27, 83-89. PubMed  Europe PubMed
  38. Lijnen,H.R., Wiman,B. and Collen,D.
    Partial primary structure of human alpha2-antiplasmin - homology with other plasma protease inhibitors
    Thromb Haemost48, 311-314. PubMed  Europe PubMed
  39. Miles,L.A., Plow,E.F., Donnelly,K.J., Hougie,C. and Griffin,J.H.
    A bleeding disorder due to deficiency of alpha 2-antiplasmin
    Blood59, 1246-1251. PubMed  Europe PubMed
  40. [YEAR:1-6-1982]Nilsson,T. and Wiman,B.
    On the structure of the stable complex between plasmin and alpha-2-antiplasmin
    FEBS Lett142, 111-114. PubMed  Europe PubMed DOI
  41. [YEAR:26-7-1982]Nilsson,T., Sjoholm,I. and Wiman,B.
    Circular dichroism studies on alpha 2-antiplasmin and its interactions with plasmin and plasminogen
    Biochim Biophys Acta705, 264-270. PubMed  Europe PubMed
  42. [YEAR:25-12-1982]Tamaki,T. and Aoki,N.
    Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor
    J Biol Chem257, 14767-14772. PubMed  Europe PubMed
  43. Teger-Nilsson,A.-C., Friberger,P. and Gyzander,E.
    Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate
    Scand J Clin Lab Invest42, 403-409. DOI  A
  44. [YEAR:15-10-1982]Wiman,B., Nilsson,T. and Cedergren,B.
    Studies on a form of alpha 2-antiplasmin in plasma which does not interact with the lysine-binding sites in plasminogen
    Thromb Res28, 193-199. PubMed  Europe PubMed
  45. Yoshioka,A., Kamitsuji,H., Takase,T., Iida,Y., Tsukada,S., Mikami,S. and Fukui,H.
    Congenital deficiency of alpha 2-plasmin inhibitor in three sisters
    Haemostasis11, 176-184. PubMed  Europe PubMed  M  I
    46. 1981
  46. Clemmensen,I., Thorsen,S., Mullertz,S. and Petersen,L.C.
    Properties of three different molecular forms of the alpha 2 plasmin inhibitor
    Eur J Biochem120, 105-112. PubMed  Europe PubMed
  47. [YEAR:1-1-1981]Kluft,C. and Los,N.
    Demonstration of two forms of alpha 2-antiplasmin in plasma by modified crossed immunoelectrophoresis
    Thromb Res21, 65-71. PubMed  Europe PubMed
  48. Korninger,C. and Collen,D.
    Neutralization of human extrinsic (tissue-type) plasminogen activator in human plasma: no evidence for a specific inhibitor
    Thromb Haemost46, 662-665. PubMed  Europe PubMed
  49. Plow,E.F. and Collen,D.
    The presence and release of alpha 2-antiplasmin from human platelets
    Blood58, 1069-1074. PubMed  Europe PubMed
  50. Wiman,B.
    [32] Human alpha-2-antiplasmin
    Methods Enzymol80, 395-408. DOI  V
    51. 1980
  51. Aoki,N., Sakata,Y., Matsuda,M. and Tateno,K.
    Fibrinolytic states in a patient with congenital deficiency of alpha 2-plasmin inhibitor
    Blood55, 483-488. PubMed  Europe PubMed  M
  52. [YEAR:1-2-1980]Matsuda,M., Wakabayashi,K., Aoki,N. and Morioka,Y.
    Alpha 2-Plasmin inhibitor is among acute phase reactants
    Thromb Res17, 527-532. PubMed  Europe PubMed
  53. [YEAR:10-4-1980]Plow,E.F., Wiman,B. and Collen,D.
    Changes in antigenic structure and conformation of alpha 2-antiplasmin induced by interaction with plasmin
    J Biol Chem255, 2902-2906. PubMed  Europe PubMed
  54. [YEAR:1-4-1980]Sandbjerg Hansen,M. and Clemmensen,I.
    Partial purification and characterization of a new fast-acting plasmin inhibitor from human platelets. Evidence for non-identity with the known plasma proteinase inhibitors
    Biochem J187, 173-180. PubMed  Europe PubMed
  55. [YEAR:1-10-1980]Wiman,B.
    Affinity-chromatographic purification of human alpha 2-antiplasmin
    Biochem J191, 229-232. PubMed  Europe PubMed
    56. 1979
  56. Aoki,N., Saito,H., Kamiya,T., Koie,K., Sakata,Y. and Kobakura,M.
    Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency
    J Clin Invest63, 877-884. PubMed  Europe PubMed  M
  57. Aoki,N.
    Natural inhibitors of fibrinolysis
    Prog Cardiovasc Dis21, 267-286. PubMed  Europe PubMed
  58. Collen,D. and Wiman,B.
    Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma
    Blood53, 313-324. PubMed  Europe PubMed
  59. [YEAR:12-5-1979]Collen,D.
    alpha2-Antiplasmin inhibitor deficiency
    Lancet1, 1039-1040. PubMed  Europe PubMed  M
  60. Collen,D. and Verstraete,M.
    alpha 2-Antiplasmin consumption and fibrinogen breakdown during thrombolytic therapy
    Thromb Res14, 631-639. PubMed  Europe PubMed
  61. Gallimore,M.J., Amundsen,E., Aasen,A.O., Larsbraaten,M., Lyngaas,K. and Svendsen,L.
    Studies on plasma antiplasmin activity using a new plasmin specific chromogenic tripeptide substrate
    Thromb Res14, 51-60. PubMed  Europe PubMed
  62. [YEAR:28-7-1979]Kluft,C., Vellenga,E. and Brommer,E.J.
    Homozygous alpha 2-antiplasmin deficiency
    Lancet2, 206-206. PubMed  Europe PubMed  M
  63. Saito,H., Goldsmith,G.H., Moroi,M. and Aoki,N.
    Inhibitory spectrum of alpha2-plasmin inhibitor
    Proc Natl Acad Sci U S A76, 2013-2017. PubMed  Europe PubMed
  64. [YEAR:25-9-1979]Wiman,B. and Collen,D.
    On the mechanism of the reaction between human alpha 2-antiplasmin and plasmin
    J Biol Chem254, 9291-9297. PubMed  Europe PubMed
  65. [YEAR:25-7-1979]Wiman,B., Lijnen,H.R. and Collen,D.
    On the specific interaction between the lysine-binding sites in plasmin and complementary sites in alpha2-antiplasmin and in fibrinogen
    Biochim Biophys Acta579, 142-154. PubMed  Europe PubMed
    66. 1978
  66. [YEAR:28-2-1978]Aoki,N., Moroi,M. and Tachiya,K.
    Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin
    Thromb Haemost39, 22-31. PubMed  Europe PubMed
  67. [YEAR:1-11-1978]Christensen,U. and Clemmensen,I.
    Purification and reaction mechanisms of the primary inhibitor of plasmin from human plasma
    Biochem J175, 635-641. PubMed  Europe PubMed
  68. Collen,D. and Wiman,B.
    Fast-acting plasmin inhibitor in human plasma
    Blood51, 563-569. PubMed  Europe PubMed
  69. [YEAR:23-12-1978]Koie,K., Kamiya,T., Ogata,K. and Takamatsu,J.
    Alpha2-plasmin-inhibitor deficiency (Miyasato disease)
    Lancet2, 1334-1336. PubMed  Europe PubMed  M
  70. Naito,K. and Aoki,N.
    Assay of alpha2-plasmin inhibitor activity by means of a plasmin specific tripeptide substrate
    Thromb Res12, 1147-1156. PubMed  Europe PubMed
  71. [YEAR:1-6-1978]Wiman,B., Boman,L. and Collen,D.
    On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin
    Eur J Biochem87, 143-146. PubMed  Europe PubMed
  72. [YEAR:15-3-1978]Wiman,B. and Collen,D.
    On the kinetics of the reaction between human antiplasmin and plasmin
    Eur J Biochem84, 573-578. PubMed  Europe PubMed
    73. 1977
  73. Aoki,N., Moroi,M., Matsuda,M. and Tachiya,K.
    The behavior of alpha2-plasmin inhibitor in fibrinolytic states
    J Clin Invest60, 361-369. PubMed  Europe PubMed DOI
  74. [YEAR:1-5-1977]Christensen,U. and Clemmensen,I.
    Kinetic properties of the primary inhibitor of plasmin from human plasma
    Biochem J163, 389-391. PubMed  Europe PubMed
  75. [YEAR:13-10-1977]Edy,J. and Collen,D.
    The interaction in human plasma of antiplasmin, the fast-reacting plasmin inhibitor, with plasmin, thrombin, trypsin and chymotrypsin
    Biochim Biophys Acta484, 423-432. PubMed  Europe PubMed
  76. Moroi,M. and Aoki,N.
    Inhibition of plasminogen binding to fibrin by alpha2-plasmin inhibitor
    Thromb Res10, 851-856. PubMed  Europe PubMed
  77. Moroi,M. and Aoki,N.
    On the interaction of alpha2-plasmin inhibitor and proteases. Evidence for the formation of a covalent crosslinkage and non-covalent weak bondings between the inhibitor and proteases
    Biochim Biophys Acta482, 412-420. PubMed  Europe PubMed
    78. 1976
  78. Bagge,L., Bjork,I., Saldeen,T. and Wallin,R.
    Purification and characterization of an inhibitor of plasminogen activation from post-traumatic patients
    Forensic Sci7, 83-86.
  79. [YEAR:1-10-1976]Collen,D.
    Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma
    Eur J Biochem69, 209-216. PubMed  Europe PubMed
  80. [YEAR:10-10-1976]Moroi,M. and Aoki,N.
    Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis
    J Biol Chem251, 5956-5965. PubMed  Europe PubMed
  81. [YEAR:1-12-1976]Mullertz,S. and Clemmensen,I.
    The primary inhibitor of plasmin in human plasma
    Biochem J159, 545-553. PubMed  Europe PubMed
    82. 1972
  82. Ganguly,P.
    A low molecular weight antiplasmin of human blood platelets
    Clin Chim Acta39, 466-468. PubMed  Europe PubMed
    83. 1970
  83. [YEAR:31-10-1970]Wakabayashi,K., Fujikawa,K. and Abe,T.
    Some properties of an antiplasmin substance from rabbit platelets
    Thromb Diath Haemorrh24, 76-84. PubMed  Europe PubMed
    84. 1966
  84. [YEAR:10-11-1966]Rimon,A., Shamash,Y. and Shapiro,B.
    The plasmin inhibitor of human plasma. IV. Its action on plasmin, trypsin, chymotrypsin, and thrombin
    J Biol Chem241, 5102-5107. PubMed  Europe PubMed
    85. 1958
  85. [YEAR:1-7-1958]Norman,P.S.
    Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma
    J Exp Med108, 53-68. PubMed  Europe PubMed
  86. [YEAR:1-11-1958]Norman,P.S. and Hill,B.M.
    Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma
    J Exp Med108, 639-649. PubMed  Europe PubMed

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2025 EBI
Terms of use